Literature DB >> 24934242

Metabolic derangement and cardiac injury early after reperfusion following intermittent cross-clamp fibrillation in patients undergoing coronary artery bypass graft surgery using conventional or miniaturized cardiopulmonary bypass.

Bao A V Nguyen1, M-Saadeh Suleiman, Jonathan R Anderson, Paul C Evans, Francesca Fiorentino, Barnaby C Reeves, Gianni D Angelini.   

Abstract

Myocardial ischemic stress and early reperfusion injury in patients undergoing coronary artery bypass grafting (CABG) operated on using intermittent cross-clamp fibrillation (ICCF) are not presently known. The role of mini-cardiopulmonary bypass (mCPB) versus conventional CPB (cCPB) during ICCF has not been investigated. These issues have been addressed as secondary objective of randomised controlled trial (ISRCTN30610605) comparing cCPB and mCPB. Twenty-six patients undergoing primary elective CABG using ICCF were randomised to either cCPB or mCPB. Paired left ventricular biopsies collected from 21 patients at the beginning and at the end of CPB were used to measure intracellular substrates (ATP and related compounds). Cardiac troponin T (cTnT) and CK-MB levels were measured in plasma collected from all patients preoperatively and after 1, 30, 60, 120, and 300 min after institution of CPB. ICCF was associated with significant ischemic stress as seen by fall in energy-rich phosphates early after reperfusion. There was also a fall in nicotinamide adenine dinucleotide (NAD(+)) indicating cardiomyocyte death which was confirmed by early release of cTnT and CK-MB during CPB. Ischemic stress and early myocardial injury were similar for cCPB and mCPB. However, the overall cardiac injury was significantly lower in the mCPB group as measured by cTnT (mean ± SEM: 96 ± 14 vs. 59 ± 8 µg/l, p = 0.02), but not with CK-MB. ICCF is associated with significant metabolic derangement and early myocardial injury. This early outcome was not affected by the CPB technique. However, the overall cardiac injury was lower for mCPB only when measured using cTnT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24934242     DOI: 10.1007/s11010-014-2122-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

2.  Feasibility and safety of minimized cardiopulmonary bypass in major aortic surgery.

Authors:  Aziz U Momin; Mansour T A Sharabiani; Emadin Kidher; Ali Najefi; John W Mulholland; Barnaby C Reeves; Gianni D Angelini; Jon R Anderson
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-28

3.  Continuous hypothermic arrest versus intermittent ischemia for myocardial protection during coronary revascularization.

Authors:  J K Koster; L H Cohn; J J Collins; J H Sanders; J E Muller; E Young
Journal:  Ann Thorac Surg       Date:  1977-10       Impact factor: 4.330

4.  Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery.

Authors:  H Imura; M Caputo; A Parry; A Pawade; G D Angelini; M S Suleiman
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

5.  A prospective randomised multicentre clinical comparison of a minimised perfusion circuit versus conventional cardiopulmonary bypass.

Authors:  Aschraf El-Essawi; Tomas Hajek; Jirji Skorpil; Andreas Böning; Frantisek Sabol; Harald Hausmann; Yuri Ostrovsky; Wolfgang Harringer
Journal:  Eur J Cardiothorac Surg       Date:  2010-03-04       Impact factor: 4.191

6.  Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.

Authors:  F Di Lisa; R Menabò; M Canton; M Barile; P Bernardi
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

7.  Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution.

Authors:  Toshihiro Ohata; Masataka Mitsuno; Mitsuhiro Yamamura; Hiroe Tanaka; Yasuhiko Kobayashi; Masaaki Ryomoto; Yoshiteru Yoshioka; Noriko Tsujiya; Yuji Miyamoto
Journal:  ASAIO J       Date:  2008 Mar-Apr       Impact factor: 2.872

8.  Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass.

Authors:  Sudip Ghosh; Manuel Galiñanes
Journal:  J Thorac Cardiovasc Surg       Date:  2003-07       Impact factor: 5.209

9.  Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function.

Authors:  W J van Boven; W B Gerritsen; F G Waanders; F J Haas; L P Aarts
Journal:  Perfusion       Date:  2004-07       Impact factor: 1.972

10.  Comparison of two strategies for myocardial management during coronary artery operations.

Authors:  J R Anderson; M Hossein-Nia; P Kallis; M Pye; D W Holt; A J Murday; T Treasure
Journal:  Ann Thorac Surg       Date:  1994-09       Impact factor: 4.330

View more
  6 in total

Review 1.  Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS).

Authors:  Kyriakos Anastasiadis; John Murkin; Polychronis Antonitsis; Adrian Bauer; Marco Ranucci; Erich Gygax; Jan Schaarschmidt; Yves Fromes; Alois Philipp; Balthasar Eberle; Prakash Punjabi; Helena Argiriadou; Alexander Kadner; Hansjoerg Jenni; Guenter Albrecht; Wim van Boven; Andreas Liebold; Fillip de Somer; Harald Hausmann; Apostolos Deliopoulos; Aschraf El-Essawi; Valerio Mazzei; Fausto Biancari; Adam Fernandez; Patrick Weerwind; Thomas Puehler; Cyril Serrick; Frans Waanders; Serdar Gunaydin; Sunil Ohri; Jan Gummert; Gianni Angelini; Volkmar Falk; Thierry Carrel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-01-26

2.  Sevoflurane preconditioning in on-pump coronary artery bypass grafting: a meta-analysis of randomized controlled trials.

Authors:  Yan Lu; Liwei Wang; Na Liu; Tianxin Dong; Ruhong Li
Journal:  J Anesth       Date:  2016-08-16       Impact factor: 2.078

3.  Relationship between platelet mass index and postoperative atrial fibrillation after elective coronary artery bypass surgery: a retrospective study.

Authors:  Ozge Guzelburc; Ahmet Zengin; Mehmet Baran Karatas; Sevinc Bayer Erdogan; Ayse Emre
Journal:  Herz       Date:  2022-09-05       Impact factor: 1.740

4.  β1 integrin is a sensor of blood flow direction.

Authors:  Ioannis Xanthis; Celine Souilhol; Jovana Serbanovic-Canic; Hannah Roddie; Antreas C Kalli; Maria Fragiadaki; Raymond Wong; Dhruv R Shah; Janet A Askari; Lindsay Canham; Nasreen Akhtar; Shuang Feng; Victoria Ridger; Jonathan Waltho; Emmanuel Pinteaux; Martin J Humphries; Matthew T Bryan; Paul C Evans
Journal:  J Cell Sci       Date:  2019-06-03       Impact factor: 5.285

5.  Effects of on-pump versus off-pump coronary artery bypass grafting on myocardial metabolism.

Authors:  Hong-Tao Xie; Xiao-Qin Kang; Shun Zhang; Yong-Cang Tian; De-Jun Liu; Ben-Jian Bai
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Systematic review of pre-clinical therapies for post-operative atrial fibrillation.

Authors:  Chanhee Seo; Connor Michie; Benjamin Hibbert; Darryl R Davis
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.